Search

everythinglearnresearchcommunity

for

Search:↓

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Lifestyle changes and environmental strategies can help address declining testosterone levels.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Alopecia areata may be linked to higher heart disease risk.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Early hair loss may predict heart disease.

Alopecia areata may be linked to heart issues.

Long COVID causes lasting symptoms in many body systems, needing more research for better treatments.

Technological advancements and standardization are crucial for improving diagnostic accuracy and laboratory efficiency.

Metabolic syndrome may worsen certain skin conditions, and managing both together is important.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Topical minoxidil can help regrow hair with regular use, but results vary and side effects may occur.

Testosterone may both worsen and protect against COVID-19 effects in men.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

People with alopecia areata have higher levels of a heart disease marker in their blood.